Table 1 Patient demographics
From: The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients’ survival
Factor | Number or median N = 155 | % or range |
|---|---|---|
Age | 69 | 47–88 |
Male/female | 68/87 | 44%/56% |
CA19-9 | 125 | 31–845 (IQR) |
CA125 | 22 | 12–42 (IQR) |
Diabetes | 31 | 20% |
Jaundice | 82 | 53% |
Tumour size | ||
T1 | 24 | 15% |
T2 | 89 | 57% |
T3 | 26 | 17% |
Indeterminate | 16 | 10% |
Tumour location | ||
Head | 121 | 78% |
Neck | 29 | 19% |
Body | 3 | 2% |
Tail | 2 | 1% |
PET SUVmax | ||
< 5 | 31 | 20% |
5–10 | 61 | 39% |
> 10 | 17 | 11% |
PET not done | 46 | 30% |
Neoadjuvant chemotherapy | 79 | 51% |
Tumour resectability | ||
Upfront | 62 | 40% |
Borderline | 53 | 34% |
Locally advanced | 40 | 26% |
Procedure | ||
PD | 81 | 52% |
DP | 13 | 8% |
TP | 4 | 3% |